Dashboard
Manage Tickers

CNTGCentogene N.V.

Nasdaq centogene.com


$ 0.57 $ 0.21 (61.57 %)    

Wednesday, 07-Aug-2024 16:18:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.72 $ -13.86 (-3.11 %)
DIA $ 387.79 $ -2.19 (-0.56 %)
SPY $ 518.50 $ -3.49 (-0.67 %)
TLT $ 95.87 $ -0.68 (-0.7 %)
GLD $ 220.55 $ -0.15 (-0.07 %)
$ 0.325
$ 0.39
$ 0.57 x 1,000
-- x --
$ 0.39 - $ 0.60
$ 0.25 - $ 1.53
83,289
na
9.56M
$ 0.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

centogene-announces-initial-data-from-ropad-study-showing-90-of-genetically-confirmed-parkinsons-patients-have-lrrk2-or-gba1-variants-findings-indicate-15-of-pd-cases-linked-to-genetic-variants-data-published-in-brain-journal-highlights-importance-of-genetic-testing-in-gene-targeted-trials
Centogene Announces Initial Data From ROPA...
08/01/2024 20:50:15

centogene-and-c-path-sign-mou-for-collaboration-in-lysosomal-disease-research-and-drug-development
Centogene And C-Path Sign MOU For Collabor...
06/20/2024 12:12:34

centogene-shares-are-trading-higher-after-the-company-reported-a-year-over-year-increase-in-fy23-eps-results
Centogene shares are trading higher after ...
05/16/2024 12:18:37

centogene-fy23-eps-127-vs-119-revenue-485-million-up-from-475-million-yoy
CENTOGENE FY23 EPS €(1.27) Vs €(1.19); Rev...
05/15/2024 21:20:24

centogene-entered-into-agrements-with-lifera-provides-20m-funding
CENTOGENE Entered Into Agrements With Life...
05/15/2024 21:11:26

Core News & Articles
CENTOGENE And Evotec Announce Discovery Of...
05/14/2024 12:53:09

CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies...

why-wang--lee-group-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket
Why Wang & Lee Group Shares Are Trading Hi...
04/19/2024 09:45:48

centogene-receives-non-compliance-notification-letter-dated-march-27-2024-from-nasdaq
Centogene Receives Non-Compliance Notifica...
04/02/2024 20:32:08

In accordance with Listing Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a period of 180 calendar days from t...

Core News & Articles
CENTOGENE Extends Strategic Partnership Wi...
03/19/2024 10:32:07

Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases...

centogene-collaborates-on-research-published-in-science-showing-immunopathological-landscape-of-human-pre-tcr-deficiency
CENTOGENE Collaborates On Research Publish...
02/29/2024 22:07:59

CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and ne...

centogene-reveals-receipt-of-nasdaq-notice-of-delisting-and-intention-to-request-a-hearing
Centogene Reveals Receipt Of Nasdaq Notice...
02/28/2024 11:37:56

centogene-says-it-is-exploring-a-range-of-strategic-alternatives-focused-on-sustainable-long-term-value-creation-for-the-benefit-of-its-stakeholders
Centogene Says It Is Exploring A Range Of ...
02/28/2024 11:33:34

The company received a staff determination letter (the "Letter") on Feb. 27, 2024, from the Listing Qualifications Depa...

centogene-and-the-laboratory-of-human-genetics-of-infectious-diseases-at-institut-imagine-announced-rare-disease-research-collaboration-specific-targets-of-the-collaboration-were-not-disclosed
Centogene And The Laboratory Of Human Gene...
01/25/2024 11:48:18

As part of the collaboration, CENTOGENE and the Lab will leverage the CENTOGENE Biodatabank, which contains over 70 million uni...

centogene-has-been-recognized-by-french-ministry-of-higher-education-and-research-as-qualified-organization-to-support-partners-conducting-rd-projects-in-france-it-has-received-accreditation-under-the-french-rd-tax-credit-initiative-for-three-years-8k
Centogene Has Been Recognized By French Mi...
01/24/2024 11:33:48

centogene-and-michael-j-fox-foundation-for-parkinsons-research-announced-research-project-on-genetic-risk-factors-associated-with-parkinsons-disease-specifically-targeting-the-role-of-variants-in-gba-glucosylceramidase-beta-gene
Centogene And Michael J. Fox Foundation Fo...
01/23/2024 11:39:14

centogene-announced-preliminary-unaudited-revenue-for-full-year-2023-between-approximately-485m-and-490m-reflecting-a-growth-rate-over-2022-in-the-mid-single-digits
Centogene Announced Preliminary Unaudited ...
01/18/2024 11:32:45

centogene-says-reached-its-initial-recruitment-and-genetic-testing-milestone-in-observational-efront-study
Centogene Says Reached Its Initial Recruit...
12/13/2023 11:32:23

Having met this milestone, CENTOGENE will continue to work with its extensive network of 30,000 physicians and enroll patients ...

centogene-expands-multiomic-diagnostic-portfolio-with-newly-launched-transcriptomic-offering
Centogene Expands Multiomic Diagnostic Por...
10/10/2023 10:34:31

Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases...

centogene-reports-h1-total-revenues-increase-of-151-reaffirms-its-guidance-for-2023-annual-revenue-growth-of-10-15
Centogene Reports H1 Total Revenues Increa...
09/07/2023 21:18:41

centogene-announced-data-confirming-the-utility-of-lyso-gb1-glucosylsphingosine-as-a-sensitive-biomarker-for-gaucher-disease-the-findings-from-the-study-also-indicate-lyso-gb1-could-help-to-predict-clinical-course-improve-personalized-care
Centogene Announced Data Confirming The Ut...
09/01/2023 12:03:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION